Wong Lab Publications
Learn more about research being performed in the Wong Lab by reading our latest publications.
Recent Publications
Author Correction: Mechanisms and clinical activity of an EGFR and HER2 exon 20-selective kinase inhibitor in non-small cell lung cancer
Nature medicine. 2024 Aug 20;
Clinical validation of a cell-free DNA fragmentome assay for augmentation of lung cancer early detection
Cancer discovery. 2024 Jun 03;
Acquired Cross-resistance in Small Cell Lung Cancer due to Extrachromosomal DNA Amplification of MYC paralogs
Cancer discovery. 2024 May 01; 14:804-827
Glutamine antagonist DRP-104 suppresses tumor growth and enhances response to checkpoint blockade in KEAP1 mutant lung cancer
Science advances. 2024 Mar 29; 10:eadm9859
EML4-ALK fusions drive lung adeno-to-squamous transition through JAK-STAT activation
Journal of experimental medicine. 2024 Mar 04; 221:
EZH2 inhibition promotes tumor immunogenicity in lung squamous cell carcinomas
Cancer research communications. 2024 Feb 13; 4:388-403
A Phase 1/2 multicenter trial of DKN-01 as monotherapy or in combination with docetaxel for the treatment of metastatic castration-resistant prostate cancer (mCRPC)
Prostate cancer & prostatic diseases. 2024 Feb 10;
FGFR inhibition augments anti-PD-1 efficacy in murine FGFR3-mutant bladder cancer by abrogating immunosuppression
Journal of clinical investigation. 2024 Jan 16; 134: